Pan-cancer analyses reveal that increased Hedgehog activity correlates with tumor immunosuppression and resistance to immune checkpoint inhibitors.
Pan-cancer analyses reveal that increased Hedgehog activity correlates with tumor immunosuppression and resistance to immune checkpoint inhibitors.
复制标题
DOI:
10.1002/cam4.4456
复制
发表时间:
2022-03
期刊:
影响因子:
4
通讯作者:
Teng L
中科院分区:
文献类型:
--
作者:
Jiang J;Ding Y;Chen Y;Lu J;Chen Y;Wu G;Xu N;Wang H;Teng L
Immune checkpoint inhibitors (ICIs) have shown numerous clinical benefits in multiple cancer types, but good predictive biomarkers are severely lacking. Although increasing evidence has linked Hedgehog (Hh) signaling pathway with tumor development, a systematic investigation for its potential as a biomarker remains elusive. We collected and analyzed the transcriptional data and clinical outcomes of diverse cancers from the Cancer Genome Atlas and four published ICI datasets. Hh activity was estimated by conducting a single‐sample gene‐set enrichment analysis (ssGSEA) for the Hh‐related genes and calculating the ssGSEA score in each tumor sample. Our findings suggest that tumors with high Hh activity displayed multiple immunosuppressive characteristics, including lack of anti‐tumor response pathways, downregulation of immune effectors, enrichment of immunosuppressive cells and chemokines, and activation of immunosuppressive signaling. Notably, patients in the non‐response group had enriched Hh activity and showed worse overall survival (OS; pooled HR = 1.50, 95% CI = 1.02–2.21, p = 0.039). In the subgroup of high programmed cell death ligand 1 (PD‐L1) expression, patients who harbored high Hh activity displayed a dramatically lower response rate to ICIs and a strikingly worse OS (pooled HR = 2.89, 95% CI = 1.53–5.49, p < 0.001). Increased Hh activity correlates with tumor immunosuppression across diverse cancers. Hh activity is not only a predictive biomarker for resistance to ICIs but can also better predict clinical outcomes in combination with PD‐L1 expression. This study highlights that increased Hedgehog (Hh) activity correlated with multiple immunosuppressive characteristics in the tumor microenvironment of diverse cancers. Moreover, Hh activity was a predictive biomarker for resistance to immune checkpoint inhibitor therapy in patients with metastatic cancer. Furthermore, combination with programmed cell death ligand 1 expression was able to better predict clinical outcomes than a single biomarker.
登录
查看更多内容
影响因子:
--
作者:
Chakrabarti, Jayati;Holokai, Loryn;Zavros, Yana
通讯作者:
Zavros, Yana
DOI:
10.1056/nejmoa1613493
发表时间:
2017-06-22
期刊:
The New England journal of medicine
影响因子:
--
作者:
Carbone DP;Reck M;Paz-Ares L;Creelan B;Horn L;Steins M;Felip E;van den Heuvel MM;Ciuleanu TE;Badin F;Ready N;Hiltermann TJN;Nair S;Juergens R;Peters S;Minenza E;Wrangle JM;Rodriguez-Abreu D;Borghaei H;Blumenschein GR Jr;Villaruz LC;Havel L;Krejci J;Corral Jaime J;Chang H;Geese WJ;Bhagavatheeswaran P;Chen AC;Socinski MA;CheckMate 026 Investigators
通讯作者:
CheckMate 026 Investigators
DOI:
10.1126/science.aar3593
发表时间:
2018-10-12
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Cristescu R;Mogg R;Ayers M;Albright A;Murphy E;Yearley J;Sher X;Liu XQ;Lu H;Nebozhyn M;Zhang C;Lunceford JK;Joe A;Cheng J;Webber AL;Ibrahim N;Plimack ER;Ott PA;Seiwert TY;Ribas A;McClanahan TK;Tomassini JE;Loboda A;Kaufman D
通讯作者:
Kaufman D
影响因子:
28.4
作者:
Jabbour, Salma K.;Berman, Abigail T.;Malhotra, Jyoti
通讯作者:
Malhotra, Jyoti
影响因子:
5.5
作者:
Caimano M;Lospinoso Severini L;Loricchio E;Infante P;Di Marcotullio L
通讯作者:
Di Marcotullio L